Podcast
The Promise of Cell & Gene Therapy to Reshape Healthcare, with Devyn Smith, CEO Arbor Biotech
“Gene editing and cell therapy, they’re going to be entrenched modalities, much like small molecules and antibodies are today, that will fundamentally reshape healthcare.” says Devyn Smith. Devyn Smith, CEO of Arbor Biotechnologies and Chairman of the Alliance for Regenerative
20 December 2024